United States · Funded startup

Who invested in Eleven Biotherapeutics

3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$75Mraised across 3 rounds since 2010, from 3 sources

$35MSeries A$20MSeries A$20MRound
Latest round
Round, $20MNov 2014
Biggest round
$35MSeries A · Mar 2010
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20102011201220132014
$35MSeries A$20MSeries A$20MRound
First round
Series A, $35M
Mar 2010
Biggest round
$35M
Series A · Mar 2010
Usual gap between rounds
2.6 years
the median of 2

The rounds

  1. Nov 2014
    Round$20M

    No investor was named in the report.

    From a historical funding recordSEC filing: $20M sold, first sale Dec 2014

  2. May 2012
  3. Mar 2010
    Series A$35M2 new

    Reported by onbiovc.comSEC filing: $4.5M sold, first sale Feb 2010

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Third Rock VenturesVC firm2rounds
JAFCOCompany1round
JAFCO AsiaInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Eleven Biotherapeutics

Who invested in Eleven Biotherapeutics?

Eleven Biotherapeutics's investors include Flagship Pioneering, LLC, Third Rock Ventures, JAFCO and JAFCO Asia.

How much has Eleven Biotherapeutics raised?

Eleven Biotherapeutics has raised $75M across 3 rounds since 2010.

When did Eleven Biotherapeutics last raise?

Eleven Biotherapeutics's most recent round was an Undisclosed round of $20M in Nov 2014.

What was Eleven Biotherapeutics's biggest round?

Eleven Biotherapeutics's largest round on record is $35M (Series A), in Mar 2010.

Who backed Eleven Biotherapeutics first?

Eleven Biotherapeutics's first round on record, in Mar 2010, was backed by Flagship Pioneering, LLC and Third Rock Ventures.

What stage is Eleven Biotherapeutics at?

Eleven Biotherapeutics's latest named round is an Undisclosed round, in Nov 2014.

Where is Eleven Biotherapeutics based?

Eleven Biotherapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.